Page last updated: 2024-08-21

dihydroergotamine and Electrocardiogram QT Prolonged

dihydroergotamine has been researched along with Electrocardiogram QT Prolonged in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Haugen, G; Kellerman, DJ; Kori, S; Voloshko, P	1

Trials

1 trial(s) available for dihydroergotamine and Electrocardiogram QT Prolonged

Article	Year
Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers. Clinical therapeutics, 2012, Volume: 34, Issue:9 Topics: Administration, Inhalation; Adult; Aza Compounds; Cross-Over Studies; Dihydroergotamine; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Quinolines; Vasoconstrictor Agents; Young Adult	2012

Article

Year

Effects of a supratherapeutic dose of investigational orally inhaled dihydroergotamine (MAP0004) on QT interval: a randomized, double-blind, active- and placebo-controlled crossover study in healthy volunteers.

Clinical therapeutics, 2012, Volume: 34, Issue:9

Topics: Administration, Inhalation; Adult; Aza Compounds; Cross-Over Studies; Dihydroergotamine; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Humans; Long QT Syndrome; Male; Middle Aged; Moxifloxacin; Quinolines; Vasoconstrictor Agents; Young Adult

2012